PCM
AGN

Pennant Capital Management’s Allergan plc AGN Stock Holding History

Pennant Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,100,000
Closed -$253M – 48
2016
Q3 		$253M Hold
1,100,000
– – 8.87% 1
2016
Q2 		$254M Buy
1,100,000
+600,000
+120% +$138M 6.52% 3
2016
Q1 		$134M Buy
+500,000
New +$143M 3.83% 6

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pennant Capital Management's AGN Position: Q4 2016 in Review

Pennant Capital Management sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 621,214 shares — an estimated $143M sold.

Pennant Capital Management first reported a position in AGN in Q2 2015 and held it in 6 quarters. The position peaked at $271M in Q2 2016. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Pennant Capital Management reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Pennant Capital Management sold 621,214 Allergan plc shares in Q4 2016, an estimated $143M.
  • Pennant Capital Management first reported a position in Allergan plc in Q2 2015 and held it in 6 quarters.
  • Pennant Capital Management's Allergan plc position peaked at $271M in Q2 2016.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Pennant Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.